BRTX — Biorestorative Therapies Share News
0.000.00%
Last trade - 00:00- $2.24m
- -$1.35m
- $0.36m
BioRestorative Therapies Inc expected to post a loss of 56 cents a share - Earnings Preview
Brief: Biorestorative Therapies Announces Notice Of Allowance For Patent Covering Fundamental Aspect Of Thermostem Metabolic Disease Program
Brief: Biorestorative Therapies In Substantive Discussions For Potential License Agreement For Thermostem® Metabolic Disease Program
Brief: Biorestorative Therapies Announces Receipt Of Nasdaq Non-Compliance Notice
BioRestorative Therapies Inc expected to post a loss of 51 cents a share - Earnings Preview
Brief: Biorestorative Therapies Enhances Preclinical Metabolic Program
Brief: Biorestorative Therapies Says Five-Year Agreement Includes Biorestorative Supplying Its Initial Commercial Product To Cartessa
U.S. RESEARCH ROUNDUP-3M, J&J, Nuvalent
U.S. STOCKS ON THE MOVE-WiSA Technologies, Rivian Automotive, Cigna Group
BioRestorative Therapies up as FDA clears change to study on cell therapy
Brief: BioRestorative Therapies Announces FDA Clearance Of Phase 2 BRTX-100 Clinical Study Protocol Amendment
Brief: BioRestorative, Galen Patient Recruitment Partner To Accelerate Enrollment Completion In Mid-Stage Trial of Therapy To Treat Chronic Lumbar Disc Disease
Brief: Biorestorative Therapies Files Prospectus Relates To Offer, Sale From Time To Time Of Up To 2.5 Million Shares Of Common Stock By Selling Securityholders
BioRestorative Therapies Inc reports results for the quarter ended in December - Earnings Summary
BioRestorative Therapies Inc expected to post a loss of 69 cents a share - Earnings Preview
BioRestorative Therapies Inc expected to post a loss of 69 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-MorphoSys AG, DocuSign, Invitae
BioRestorative rises on preliminary data from back pain therapy candidate
Brief: BioRestorative Therapies Presents Preliminary Clinical Data of BRTX-100